Lectures at IITD by Nobel Laureate Prof Joachim Frank, & Prof Bhanu Jena: Beyond Static Structures:…

skim AI Analysis | IIT Delhi

IIT Delhi's Lectures at IITD by Nobel Laureate Prof Joachim Frank, & Prof Bhanu Jena: Beyond Static Structures:…: skim's analysis identifies 12 key moments, with 1 potential conflict of interest flagged. Bhanu P.

Category: Science. Format: Educational. YouTube video analyzed by skim.

Summary

Bhanu P. Jena and Nobel Laureate Joachim Frank present advances in imaging cellular nanomachines at IIT Delhi. Bhanu P. Jena details the discovery of the porosome secretory complex and preclinical therapies for cystic fibrosis and Alzheimer's disease, while Joachim Frank explains how time-resolved cryo-electron microscopy captures millisecond-scale ribosome assembly intermediates.

skim AI Analysis

Credibility assessment: Primary Research Presentations. Nobel Laureate Joachim Frank and Camurus Prize winner Bhanu P. Jena present decades of peer-reviewed experimental findings in cryo-EM and atomic force microscopy. Bhanu P. Jena's translational claims on cystic fibrosis and Alzheimer's rely on his own commercial spin-offs' preclinical data and require clinical trials.

Bias assessment: Translational Founder Optimism. Joachim Frank maintains strict academic objectivity and openly notes methodological limits. Bhanu P. Jena strongly promotes the commercial and therapeutic potential of his five spin-off companies' porosome-based drug pipelines, framing preclinical organoid and mouse results as capable of reversing Alzheimer's.

Originality: 92% — Pioneering Primary Research. Both speakers share firsthand accounts of techniques and cellular structures they personally pioneered, including unpublished time-resolved cryo-EM data on bacterial ribosome subunit association and primary preclinical studies on porosome reconstitution.

Depth: 88% — Rigorous Biophysical Detail. The lectures examine molecular mechanisms at angstrom and millisecond scales, covering microfluidic mixing kinetics, free-energy landscapes, multi-body refinement eigenvectors, and lipid bilayer electrophysiology, followed by technical faculty Q&A.

Key Points (12)

1. Bhanu P. Jena introduces the porosome machine

Timestamp: 00:03:18 to 00:07:36

Human cells communicate by secreting neurotransmitters, digestive enzymes, and hormones such as insulin through a cup-shaped lipoprotein nanostructure called the porosome. Composed of over 30 proteins and measuring 15 nanometers in neurons, the porosome governs regulated cell secretion. Mutations in a single component protein disrupt protein-protein interactions and cause secretory diseases like cystic fibrosis, diabetes, and Alzheimer's.

Significance (High): Framing secretory defects as structural failures of a 30-protein nanomachine shifts therapeutic strategy from single-gene repair to whole-complex restoration.

Sources in support: Bhanu P. Jena (Distinguished Professor of Physiology, Wayne State University School of Medicine)

2. AFM proves vesicles kiss and run at porosomes

Timestamp: 00:07:36 to 00:15:18

For nearly 80 years, physiology textbooks held that secretory vesicles completely merge with the plasma membrane during secretion, which failed to explain why partially empty vesicles remain afterward. Using atomic force microscopy on live pancreatic acinar cells, Bhanu P. Jena showed that 100-nanometer pores dilate by about 25% during amylase secretion and return to normal size after 30 minutes.

Significance (High): Demonstrating transient docking and partial release overturns the classical all-or-nothing exocytosis dogma in cell physiology.

Sources in support: Bhanu P. Jena (Distinguished Professor of Physiology, Wayne State University School of Medicine)

3. Neuronal porosome architecture and lipid profile

Timestamp: 00:15:18 to 00:18:58

In presynaptic nerve terminals, porosomes measure 12 to 17 nanometers and feature an inverted cup shape with a central plug that regulates rapid neurotransmitter release. Chemical analyses of isolated synaptic vesicles and presynaptic membranes reveal completely distinct protein and lipid profiles with no overlap. Solution X-ray scattering, electron microscopy, and atomic force microscopy confirm that synaptic vesicles do not fully fuse into the presynaptic membrane.

Significance (Medium): Distinct lipidomic heat maps between vesicles and presynaptic membranes provide biochemical evidence that synaptic vesicles preserve their integrity during neurotransmission.

Sources in support: Bhanu P. Jena (Distinguished Professor of Physiology, Wayne State University School of Medicine)

4. Porosome reconstitution for cystic fibrosis

Timestamp: 00:18:58 to 00:25:25

Bhanu P. Jena explains that conventional gene and mRNA therapies for cystic fibrosis struggle because mutating the CFTR chloride channel also depletes and alters roughly 10 other associated proteins within the airway porosome complex. By reconstituting intact, purified human porosome complexes into cystic fibrosis airway organoids and mice via weekly aerosol delivery, his team reports restoring mucus secretion at twice the efficacy of Vertex Pharmaceuticals' drug Trikafta.

Significance (High): Replacing the entire multi-protein porosome complex bypasses single-gene mutation heterogeneity and could offer a mutation-agnostic therapy for cystic fibrosis.

Sources in support: Bhanu P. Jena (Distinguished Professor of Physiology, Wayne State University School of Medicine)

5. Small molecule reverses Alzheimer's in models

Timestamp: 00:25:25 to 00:33:16

In human Alzheimer's brain tissue, beta-amyloid 1-42 peptides bind to a potassium channel on the neuronal porosome, depleting key secretory proteins and impairing neurotransmission. Bhanu P. Jena presents a safe, FDA GRAS-designated small molecule that blocks beta-amyloid 1-42 from binding the porosome and disassembles existing amyloid clumps.

Significance (High): Targeting both amyloid-porosome binding and plaque aggregation addresses synaptic secretory failure alongside plaque buildup in preclinical Alzheimer's models.

Sources in support: Bhanu P. Jena (Distinguished Professor of Physiology, Wayne State University School of Medicine)

6. Nasal delivery, nanobodies, and AI modeling

Timestamp: 00:33:16 to 00:42:05

During the question-and-answer session, Bhanu P. Jena explains that reconstituted human porosomes avoid immune rejection due to their native human origin and 100-nanometer scale, while the 15-nanometer Alzheimer's therapy can be delivered nasally via the olfactory bulb at one-millionth the standard dose.

Significance (Medium): Combinatorial nanobody targeting and nasal olfactory delivery solve key bioavailability and off-target toxicity bottlenecks in nanomedicine.

Sources in support: Bhanu P. Jena (Distinguished Professor of Physiology, Wayne State University School of Medicine)

Neutral sources: YouTube: IIT Delhi (Host institution and audience members during Q&A sessions)

7. Joachim Frank on single-particle cryo-EM limits

Timestamp: 00:44:15 to 00:50:54

Joachim Frank reviews the principles of single-particle cryo-electron microscopy, where biomolecules in solution are flash-frozen in vitreous ice in random orientations and computationally aligned into three-dimensional reconstructions. Using maximum entropy classification, his lab resolved multiple static structures of the ribosome and discovered the ratchet-like motion between its subunits during translation.

Significance (Medium): Recognizing that chemical inhibitors distort native reaction states motivated the invention of inhibitor-free time-resolved cryo-EM.

Sources in support: Joachim Frank (Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate)

8. Microfluidic time-resolved cryo-EM explained

Timestamp: 00:50:54 to 00:58:46

Because conventional grid pipetting and blotting take around 5 seconds, most biomolecular reactions finish before freezing. Joachim Frank's team developed a time-resolved cryo-EM system using a microfluidic chip that mixes two reactants in 0.5 milliseconds, incubates them in a variable-length channel for 10 to 1,000 milliseconds, and sprays the droplets onto an EM grid plunging into liquid cryogen.

Significance (High): Replacing slow manual blotting with microfluidic mixing and spraying opens the millisecond time domain of domain motions to atomic-resolution imaging.

Sources in support: Joachim Frank (Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate)

9. Capturing release factor RF1 domain motion

Timestamp: 00:58:46 to 01:01:31

Joachim Frank demonstrates time-resolved cryo-EM on bacterial translation termination, resolving a paradox where X-ray crystallography showed release factor RF1 in a compact state unable to reach the peptidyl transferase center. Without any chemical inhibitors, images captured at 24 milliseconds show RF1 docked at the stop codon in its compact X-ray conformation at 3.9 angstroms resolution.

Significance (High): Directly imaging RF1 transitioning from compact to extended between 24 and 60 milliseconds resolves a discrepancy between static crystal structures and biochemical function.

Sources in support: Joachim Frank (Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate)

10. Fast and slow pathways of 70S ribosome assembly

Timestamp: 01:01:31 to 01:08:51

Sharing unpublished research, Joachim Frank investigates how 30S and 50S ribosomal subunits associate into a 70S ribosome at 10, 20, 40, and 120 milliseconds when magnesium is raised from 3.5 to 10 millimolar. Electrostatic calculations reveal that magnesium ions create complementary charge landscapes across inter-subunit bridges.

Significance (High): Revealing parallel fast-collision and slow-search assembly pathways shows how thermal conformational fluctuations govern macromolecular complex formation.

Sources in support: Joachim Frank (Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate)

11. Multibody refinement and future drug design

Timestamp: 01:08:51 to 01:15:26

To dissect the slow trial-and-error assembly pathway, Joachim Frank's team applied multibody refinement treating the 50S subunit, 30S body, and 30S head as three independent rigid bodies undergoing normal mode motions. Atomic comparisons show how an unstructured linker in protein bL31 reorganizes to form inter-subunit bridge B1b with protein uS13.

Significance (Medium): Connecting atomic-level dynamic intermediate mapping to complex targets like the porosome bridges fundamental biophysics with rational drug discovery.

Sources in support: Joachim Frank (Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate)

12. Cryo-ET validation, cryo-jetting, and spray effects

Timestamp: 01:18:43 to 01:29:42

During the question-and-answer session, Joachim Frank notes that ribosomal states discovered in vitro by single-particle cryo-EM have been confirmed in vivo by cryo-electron tomography and subtomogram averaging.

Significance (Medium): Validating microfluidic spraying against denaturation and pooling time points into a single coordinate space establishes the methodological rigor of time-resolved cryo-EM.

Sources in support: Joachim Frank (Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate)

Neutral sources: YouTube: IIT Delhi (Host institution and audience members during Q&A sessions)

Key Sources

  • Sarajj — Second-year student, Department of Design, and host, IIT Delhi
  • Bhanu P. Jena — Distinguished Professor of Physiology, Wayne State University School of Medicine
  • Joachim Frank — Professor of Biochemistry and Molecular Biophysics, Columbia University; 2017 Nobel Laureate
  • YouTube: IIT Delhi — Host institution and audience members during Q&A sessions

Potential Conflicts of Interest (1)

Bhanu P. Jena's Biotech Spin-Off Companies (Medium severity)

Type: Commercial

Bhanu P. Jena founded a company in 2021 that has spun off into five biotechnology companies, including Porosome AI, developing commercial therapeutics for cystic fibrosis and Alzheimer's disease.

Significance: This financial stake incentivizes framing his preclinical porosome reconstitution and small-molecule data as superior to existing commercial treatments like Vertex Pharmaceuticals' $12 billion drug Trikafta.

This analysis was generated by skim (skim.plus), an AI-powered content analysis platform by Credible AI. Scores and classifications represent the platform's AI-generated assessment and should be considered alongside other sources.